New #ICESOntario data show progress, but gaps remain in vaccine coverage for newcomer children in Ontario. Linking immunization and immigration data helps identify under-immunized groups and close immunity gaps. Every child deserves equal protection. 🔗www.ices.on.ca/publi...

Upcoming Town Hall: The evolving role of Sublocade as a treatment option for opioid use disorder (OUD) People can share their experiences, voice concerns, and ask questions about the growing use of Sublocade as a treatment option for OUD. Register at ca01web.zoom.us/webinar/regi...

Registration is open for the first OSSU World Café Conversation! Dec 10 at 12 p.m. EST. Discuss breaking down siloes in the patient engagement ecosystem and explore what “meaningful engagement” really means. us06web.zoom.us/meeting/regi... #PatientEngagement #OSSUtweets

The @ossupor.bsky.social is hosting a new series: “OSSU World Café Conversations” dedicated to those interested in patient engagement in research. The series will consist of 3 conversation events and is open to patients, the public, researchers and other interested groups. bit.ly/4hOJzmM

Recent study shows that 60% of patients who began take-home methadone during the first month of COVID-19 returned to daily supervised dosing within six months, highlighting the need to better understand how prescriber and clinic factors influence take-home decisions. odprn.ca/research/pub... #NAAW

A recent ODPRN study analyzing provincial harm reduction supply distribution revealed that public health units with the highest rates of opioid-related mortality also had among the highest distribution levels of harm reduction supplies. odprn.ca/research/pub...

The EMS opioid response dashboard has been updated on the Ontario Opioid Indicator Tool with new Q2 2025 data. Overall, the rate of suspected opioid toxicities treated by EMS in Ontario increased in Q2 2025 compared to Q1, although trends differed across regions. odprn.ca/ontario-opio...

New research highlights: Starting OAT after a hospital-treated opioid toxicity significantly lowers the risk of a repeat overdose. odprn.ca/research/pub... @icesontario.bsky.social @unityhealthto.bsky.social

October data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 206 suspect drug-related deaths reported in October 2025 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

At the ODPRN, we’re committed to generating research that informs clinical and policy decisions to support the wellness of people who use drugs. During #NAAW, we recognize the importance of lived experience in shaping compassionate, effective responses. #OUD #AddictionsAwareness #NAAW2025

NEW ODPRN study shows high variability in harm reduction supply distribution and opioid-related mortality across Public Health Units (PHUs) in Ontario. odprn.ca/research/pub... @icesontario.bsky.social @unityhealthto.bsky.social

NEW ODPRN study found that nearly 60% of patients who began take-home methadone treatment during the first month of COVID-19 switched back to daily supervised dosing within 6 months. Learn more at odprn.ca/research/pub... @icesontario.bsky.social @unityhealthto.bsky.social #methadone #OAT

New 2025 Q2 data on #opioid-related deaths in #Ontario from the OCC is now available. Note that the decrease in Q1&Q2 2025 reflects the continuation of a trend that began in Q3 2024. Data available for download at odprn.ca/occ-opioid-a...

“Opioids have a place in clinical practice, but it’s really about making sure that when they are accessed, [...] people have tried other alternatives, and that they’re prescribed as low dose and short a time period as possible”-Tara Gomes @theglobeandmail.com www.theglobeandmail.com/canada/artic...

The use of prescription #opioids to treat acute pain has decreased in Canada in recent years. But there’s still a need for national information on prescription opioid use specific to different populations. Read the study led by St. Michael’s researchers here: unityhealth.to/2025/10/opio... @cmaj.ca

"The vast majority of those deaths are happening among people who are not getting prescribed those opioids but who are accessing the illicit drug supply" - @taragomes.bsky.social talks about our recent study on prescription opioid use for pain in with @thestar.com www.thestar.com/news/canada/...

NEW ODPRN Town Hall report on pharmacists providing Minor Ailments Services in Ontario Read the report + listen to the audio clips from 6 of the individuals who shared live during the Town Hall. odprn.ca/town-halls/m... #minorailments #pharmacistprescribing #pharmacy

‼️ APPLICATIONS CLOSE TONIGHT ‼️ Don't forget to submit your application to the FREE ODPRN student training program! Apply at odprn.ca/about-us/stu...

New study examined trends in prescription opioid dispensing for pain across Canada and found declines that aligned with national efforts to promote more appropriate opioid use for pain management. odprn.ca/research/pub... @icesontario.bsky.social @inesss.qc.ca @unityhealthto.bsky.social

The latest Patented Medicine Prices Review Board CompassRx report shows that public drug plan prescription expenditures grew by 7.4% in 2022/23, reaching $14.1 billion. Details available from the Government of Canada at www.canada.ca/en/patented-...

Check out our student training program, applications close October 28! odprn.ca/about-us/stu...

Health Canada has approved an exemption to the Controlled Drugs and Substances Act (CDSA) for DIY Community Health to operate a drug checking service in Timmins, which aims to provide more locally accurate data regarding the toxic drug crisis. #timmins www.timminspress.com/news/new-ini...

New study co-authored by CP3’s Dr. Katie Suda found that antibiotic durations for common infections in older adults are often longer than guidelines recommend, highlighting opportunities to reduce overuse and improve antimicrobial stewardship. pubmed.ncbi.nlm.nih.gov/41050542/

⌛ Less than 2 weeks left to apply to the ODPRN Student Training Program! Don't miss out on this incredible opportunity to network with leaders in the field of drug policy research and earn a certificate through the ODPRN. There is no cost to participate in this program! odprn.ca/about-us/stu...

We are excited to announce our new website is now live! Check it out at odprn.ca

Check out our latest research minute highlighting our new study on the effectiveness and safety of direct-acting oral anticoagulants (DOACs) use among individuals with atrial fibrillation. odprn.ca/research/pub... #atrialfibrillation #doac @icesontario.bsky.social @unityhealthto.bsky.social

Findings from our new study support the real-world effectiveness and safety of direct-acting oral anticoagulants (DOACs) use among individuals with atrial fibrillation. odprn.ca/research/pub...

There is still time to apply for the student training program! Don't miss out on this incredible opportunity to learn and network with expert researchers and ministry representatives in the field of drug policy. ⏳Deadline to apply is October 28 odprn.ca/about-us/stu...

“Clearly there’s disproportionate harm among First Nations People, clearly they are accessing treatment, but perhaps not always in the best way or a way that is supportive of them,” - @taragomes.bsky.social @chiefsofontario.bsky.social @ijbstories.bsky.social ijb.utoronto.ca/news/governm...

“We need more resources, not fewer, to protect our people, safeguard our future, and provide the support essential for healing," - said Regional Chief Benedict, speaking about the ODPRN report in collaboration with @chiefsofontario.bsky.social chiefs-of-ontario.org/first-nation...

The Drug Policy Student Training Program provides students with free access to online training and incredible networking opportunities with expert leaders in the field of drug policy. Applications for our 2026 cohort is open, apply today at odprn.ca/about-us/stu...

How do drug shortages affect medication use? A study by Araniy Santhireswaran & Prof. Mina Tadrous @pharmacy.utoronto.ca reviewed studies on drug shortages & found that drug shortages often lead to significant reductions in drug utilization. 🔗Read more bit.ly/4nRoc62

Dashboards on the Ontario Opioid Indicator Tool has been updated with annual and monthly/quarterly data up to March 2025! All data available at odprn.ca/ontario-opio...

💊 Taking multiple medications? 5 questions to ask To mark Canadian Patient Safety Week, join our free webinar to learn 5 key questions to ask about your medications. 📅 Oct 29th at 12 PM ET (English) / 2 PM ET (French) 🔗 Register: deprescribingnetwork.ca/5q-webinar Open to all audiences!

Ontario expands pharmacists’ scope and plans broader roles for optometrists, psychologists, physiotherapists & more. These changes aim to boost access, cut wait times & ease pressure on ERs and family doctors. #ONhealth #Pharmacy news.ontario.ca/en/release/1...

The Drug Policy Student Training Program provides students with free access to online training and incredible networking opportunities with expert leaders in the field of drug policy. Applications for our 2026 cohort is open, apply today at odprn.ca/about-us/stu...

August data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨There were 198 suspect drug-related deaths reported in August 2025 in Ontario. Data available for download at odprn.ca/occ-opioid-a...

New ODPRN study found that from Jan 2018 - Jun 2022, majority of alcohol toxicity deaths in Ontario occurred among men, people aged 25–44, in private residences, and involved other non-alcohol substances. odprn.ca/research/pub...

Update from Toronto's Drug Checking Service shows carfentanil was found in 14% (18) of the fentanyl samples collected in Toronto - the most they have seen in a month to date. View the data at: drugchecking.community View their post at: www.instagram.com/p/DOJTpmWDq4J

The ODPRN is now accepting applications for our 2026 Drug Policy Student Training Program! Free access to online training and incredible networking opportunities with expert leaders in the field of drug policy. To learn more and apply, visit: odprn.ca/about-the-od...

For #ioad, we highlight the voices of people with lived experience, frontline harm reduction workers, healthcare providers, researchers, and members of community organizations that provide services for people who use drugs. odprn.ca/research/pub... #ioad2025 #opioiduse #oud #drugtoxicitycrisis

Leading up to #IOAD2025, we want to highlight research on Safer opioid supply (SOS). Here we found that SOS and methadone were associated with improved health outcomes, including reduced toxicities and healthcare use. Learn more at odprn.ca/research/pub...

PHO added some of ODPRN's indicators to their Substance Use and Harms Tool! ODPRN's Opioid Indicator Tool will also be updated with new data in September. www.publichealthontario.ca/en/data-and-...

Quarterly summaries of opioid-related mortality in Ontario up to Q1 2025 now available on the ODPRN website! - Rates continue to be highest in northern PHU regions - Fentanyl continues to contribute to the majority deaths More information available at odprn.ca/occ-opioid-a...

New ODPRN study finds a decrease in overall prescribing rates of opioids for pain and concurrent benzodiazepine use among First Nations People living in Ontario. Learn more at odprn.ca/research/pub... @chiefsofontario.bsky.social @cjphrcsp.bsky.social

July data on #opioid-related deaths in #Ontario from the OCC is now available. 🚨In the past 3 months, there were 605 suspect drug-related deaths in Ontario. Data available for download at odprn.ca/occ-opioid-a...

NEW ODPRN study evaluated methadone treatment trends and found higher starting doses and an increased use of combination therapy with slow-release oral morphine (SROM). @icesontario.bsky.social @unityhealthto.bsky.social odprn.ca/wp-content/u...

One day left to apply!

Canada facing nationwide shortages of Percocet, T3s https://globalnews.ca/news/11302308/painkillers-drug-shortage-acetaminophen/ 𝗠𝗼𝗿𝗲 𝗻𝗲𝘄𝘀 ⇢ CanadaHealthwatch.ca 🍁

Study Spotlight! In 2020, during the COVID-19 pandemic, only 1 in 10 opioid-related deaths in Ontario involved solely pharmaceutical opioids, marking a shift toward unregulated drug supply involvement. Read the full report: odprn.ca/research/pub...